Bank Julius Baer & Co’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33,389
Closed -$336K 569
2023
Q4
$336K Sell
33,389
-9
-0% -$82 ﹤0.01% 358
2023
Q3
$313K Buy
33,398
+656
+2% +$9.36K ﹤0.01% 357
2023
Q2
$803K Sell
32,742
-3,904
-11% -$98K ﹤0.01% 287
2023
Q1
$853K Buy
36,646
+2,543
+7% +$65K 0.01% 284
2022
Q4
$863K Buy
34,103
+2,223
+7% +$54.5K 0.01% 283
2022
Q3
$615K Sell
31,880
-65,007
-67% -$1.65M ﹤0.01% 315
2022
Q2
$2.47M Sell
96,887
-19,863
-17% -$464K 0.02% 197
2022
Q1
$3M Sell
116,750
-18,779
-14% -$557K 0.02% 197
2021
Q4
$5.67M Sell
135,529
-298,627
-69% -$11.7M 0.03% 191
2021
Q3
$18.9M Buy
434,156
+98,644
+29% +$4.27M 0.12% 118
2021
Q2
$15.9M Buy
335,512
+83,516
+33% +$3.8M 0.1% 143
2021
Q1
$12.9M Buy
251,996
+105,245
+72% +$5.67M 0.1% 141
2020
Q4
$3.93M Buy
146,751
+117,945
+409% +$3.83M 0.03% 208
2020
Q3
$989K Buy
+28,806
New +$1.24M 0.01% 296

Other funds holding VIR